Serum uric acid (SUA) is a natural antioxidant that may exert neuroprotective effects against neurodegenerative diseases. The relationship between uric acid and cognitive functions has been extensively studied, but results remain conflicting.
Objective:
To investigate potential associations between SUA level and mild cognitive impairment (MCI), and different domains of cognitive performances in patients with type 2 diabetes mellitus (T2DM).
Methods:
A total of 352 T2DM subjects (208 males and 144 females) were enrolled. SUA level was determined by using the uricase method. Cognitive performances were assessed using a validated neuropsychological test battery. Generalized additive models and binary logistic regression analysis were fitted to determine the association between SUA and cognitive functions.
Results:
A total of 157 T2DM patients had MCI, and 195 displayed normal cognition. Compared with the controls, MCI patients exhibited lower SUA level (p = 0.009). Generalized additive models revealed a U-shaped curve relationship among SUA with Montreal Cognitive Assessment, Auditory Verbal Learning Test-immediate recall and Trail Making Test-B scores (all p < 0.05). Further logistic regression analysis showed a significant trend toward decreased MCI risk with increased SUA level among the subjects whose SUA level was below the cut-point (388.63 μmol/L); each unit increment in SUA level reduced the MCI risk by 0.7% (p = 0.003).
Conclusion:
A U-shaped association between SUA level and global cognitive function, especially executive and memory function, existed in T2DM patients. Our findings will provide additional suggestions that an increase of SUA to a certain level may be a novel method to reduce the burden of T2DM-associated cognitive impairment.
ChoNH, ShawJE, KarurangaS, HuangY, da Rocha FernandesJD, OhlroggeAW, MalandaB (2018) IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract138, 271–281.
2.
XuY, WangL, HeJ, BiY, LiM, WangT, WangL, JiangY, DaiM, LuJ, XuM, LiY, HuN, LiJ, MiS, ChenCS, LiG, MuY, ZhaoJ, KongL, ChenJ, LaiS, WangW, ZhaoW, NingG, 2010 China Noncommunicable Disease Surveillance Group (2013) Prevalence and control of diabetes in Chinese adults. JAMA310, 948–959.
3.
ChengG, HuangC, DengH, WangH (2012) Diabetes as a risk factor for dementia and mild cognitive impairment: A meta-analysis of longitudinal studies. Intern Med J42, 484–491.
4.
YuanXY, WangXG (2017) Mild cognitive impairment in type 2 diabetes mellitus and related risk factors: A review. Rev Neurosci28, 715–723.
5.
AmesBN, CathcartR, SchwiersE, HochsteinP (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis. Proc Natl Acad Sci U S A78, 6858–6862.
6.
XiuS, ZhengZ, GuanS, ZhangJ, MaJ, ChanP (2017) Serum uric acid and impaired cognitive function in community-dwelling elderly in Beijing. Neurosci Lett637, 182–187.
7.
WuY, ZhangD, PangZ, JiangW, WangS, TanQ (2013) Association of serum uric acid level with muscle strength and cognitive function among Chinese aged 50-74 years. Geriatr Gerontol Int13, 672–677.
8.
LiJ, DongBR, LinP, ZhangJ, LiuGJ (2010) Association of cognitive function with serum uric acid level among Chinese nonagenarians and centenarians. Exp Gerontol45, 331–335.
9.
Mendez-HernandezE, Salas-PachecoJ, Ruano-CalderonL, Tellez-ValenciaA, Cisneros-MartinezJ, Barraza-SalasM, Arias-CarrionO (2015) Lower uric acid linked with cognitive dysfunction in the elderly. CNS Neurol Disord Drug Targets14, 564–566.
10.
EuserSM, HofmanA, WestendorpRG, BretelerMM (2009) Serum uric acid and cognitive function and dementia. Brain132, 377–382.
11.
MolshatzkiN, WeinsteinG, StreiflerJY, GoldbourtU, TanneD (2015) Serum uric acid and subsequent cognitive performance in patients with pre-existing cardiovascular disease. PLoS One10, e0120862.
12.
XueL, LiuY, XueH, XueJ, SunK, WuL, HouP (2017) Low uric acid is a risk factor in mild cognitive impairment. Neuropsychiatr Dis Treat13, 2363–2367.
13.
LiuM, WangJ, ZengJ, HeY (2017) Relationship between serum uric acid level and mild cognitive impairment in Chinese community elderly. BMC Neurol17, 146.
14.
Al-khateebE, AlthaherA, Al-khateebM, Al-MusawiH, AzzouqahO, Al-ShweikiS, ShafagojY (2015) Relation between uric acid and Alzheimer’s disease in elderly Jordanians. J Alzheimers Dis44, 859–865.
15.
KimTS, PaeCU, YoonSJ, JangWY, LeeNJ, KimJJ, LeeSJ, LeeC, PaikIH, LeeCU (2006) Decreased plasma antioxidants in patients with Alzheimer’s disease. Int J Geriatr Psychiatry21, 344–348.
16.
RinaldiP, PolidoriMC, MetastasioA, MarianiE, MattioliP, CherubiniA, CataniM, CecchettiR, SeninU, MecocciP (2003) Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol Aging24, 915–919.
17.
GaoX, O’ReillyEJ, SchwarzschildMA, AscherioA (2016) Prospective study of plasma urate and risk of Parkinson disease in men and women. Neurology86, 520–526.
18.
BonakdaranS, KharaqaniB (2014) Association of serum uric acid and metabolic syndrome in type 2 diabetes. Curr Diabetes Rev10, 113–117.
19.
ChenYY, KaoTW, YangHF, ChouCW, WuCJ, LaiCH, SunYS, WangCC, ChenWL (2018) The association of uric acid with the risk of metabolic syndrome, arterial hypertension or diabetes in young subjects- An observational study. Clin Chim Acta478, 68–73.
20.
ZhengX, GongL, LuoR, ChenH, PengB, RenW, WangY (2017) Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults. Lipids Health Dis16, 202.
21.
BorghiC, Rodriguez-ArtalejoF, De BackerG, DallongevilleJ, MedinaJ, NuevoJ, GuallarE, PerkJ, BanegasJR, TubachF, RoyC, HalcoxJP (2018) Serum uric acid levels are associated with cardiovascular risk score: A post hoc analysis of the EURIKA study. Int J Cardiol253, 167–173.
22.
BarkasF, ElisafM, LiberopoulosE, KalaitzidisR, LiamisG (2018) Uric acid and incident chronic kidney disease in dyslipidemic individuals. Curr Med Res Opin34, 1193–1199.
23.
VerhaarenBF, VernooijMW, DehghanA, VroomanHA, de BoerR, HofmanA, WittemanJC, NiessenWJ, BretelerMM, van der LugtA, IkramMA (2013) The relation of uric acid to brain atrophy and cognition: The Rotterdam Scan Study. Neuroepidemiology41, 29–34.
24.
CiceroAF, DesideriG, GrossiG, UrsoR, RosticciM, D’AddatoS, BorghiC, Brisighella Heart Study Group (2015) Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: Data from the Brisighella Study. Intern Emerg Med10, 25–31.
25.
LatourteA, SoumareA, BardinT, Perez-RuizF, DebetteS, RichetteP (2018) Uric acid and incident dementia over 12 years of follow-up: A population-based cohort study. Ann Rheum Dis77, 328–335.
26.
BeydounMA, CanasJA, DoreGA, BeydounHA, RostantOS, Fanelli-KuczmarskiMT, EvansMK, ZondermanAB (2016) Serum uric acid and its association with longitudinal cognitive change among urban adults. J Alzheimers Dis52, 1415–1430.
27.
AhlskogJE, UittiRJ, LowPA, TyceGM, NickanderKK, PetersenRC, KokmenE (1995) No evidence for systemic oxidant stress in Parkinson’s or Alzheimer’s disease. Mov Disord10, 566–573.
28.
AlbertiKG, ZimmetPZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med15, 539–553.
29.
AlbertMS, DeKoskyST, DicksonD, DuboisB, FeldmanHH, FoxNC, GamstA, HoltzmanDM, JagustWJ, PetersenRC, SnyderPJ, CarrilloMC, ThiesB, PhelpsCH (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 270–279.
30.
ZhouBF, Cooperative Meta-Analysis Group of the Working Group on Obesity in China (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci15, 83–96.
31.
GroupBDS, FryeRL, AugustP, BrooksMM, HardisonRM, KelseySF, MacGregorJM, OrchardTJ, ChaitmanBR, GenuthSM, GoldbergSH, HlatkyMA, JonesTL, MolitchME, NestoRW, SakoEY, SobelBE (2009) A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med360, 2503–2515.
32.
GrossJL, de AzevedoMJ, SilveiroSP, CananiLH, CaramoriML, ZelmanovitzT (2005) Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care28, 164–176.
33.
WilkinsonCP, FerrisFL3rd, KleinRE, LeePP, AgardhCD, DavisM, DillsD, KampikA, PararajasegaramR, VerdaguerJT, Global Diabetic Retinopathy Project Group (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology110, 1677–1682.
34.
TesfayeS, BoultonAJ, DyckPJ, FreemanR, HorowitzM, KemplerP, LauriaG, MalikRA, SpalloneV, VinikA, BernardiL, ValensiP, Toronto Diabetic Neuropathy Expert Group (2010) Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care33, 2285–2293.
35.
VinikO, WechalekarMD, FalzonL, BuchbinderR, van der HeijdeDM, BombardierC (2014) Treatment of asymptomatic hyperuricemia for the prevention of gouty arthritis, renal disease, and cardiovascular events: A systematic literature review. J Rheumatol Suppl92, 70–74.
36.
SinghJA, HodgesJS, ToscanoJP, AschSM (2007) Quality of care for gout in the US needs improvement. Arthritis Rheum57, 822–829.
37.
YuJ, LiJ, HuangX (2012) The Beijing version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment: A community-based study. BMC Psychiatry12, 156.
38.
AlagiakrishnanK, ZhaoN, MereuL, SeniorP, SenthilselvanA (2013) Montreal Cognitive Assessment is superior to Standardized Mini-Mental Status Exam in detecting mild cognitive impairment in the middle-aged and elderly patients with type 2 diabetes mellitus. Biomed Res Int2013, 186106.
39.
NasreddineZS, PhillipsNA, BedirianV, CharbonneauS, WhiteheadV, CollinI, CummingsJL, ChertkowH (2005) The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc53, 695–699.
40.
WangF, ZhaoM, HanZ, LiD, ZhangS, ZhangY, KongX, SunN, ZhangQ, LeiP (2017) Hyperuricemia as a protective factor for mild cognitive impairment in non-obese elderly. Tohoku J Exp Med242, 37–42.
41.
PellecchiaMT, SavastanoR, MocciaM, PicilloM, SianoP, ErroR, VallelungaA, AmboniM, VitaleC, SantangeloG, BaroneP (2016) Lower serum uric acid is associated with mild cognitive impairment in early Parkinson’s disease: A 4-year follow-up study. J Neural Transm (Vienna)123, 1399–1402.
42.
DuN, XuD, HouX, SongX, LiuC, ChenY, WangY, LiX (2016) Inverse association between serum uric acid levels and Alzheimer’s disease risk. Mol Neurobiol53, 2594–2599.
43.
CaoB, WeiQQ, OuR, YangJ, ShangHF (2015) Association of serum uric acid level with cognitive function among patients with multiple system atrophy. J Neurol Sci359, 363–366.
44.
BaenaCP, SuemotoCK, BarretoSM, LotufoPA, BensenorI (2017) Serum uric acid is associated with better executive function in men but not in women: Baseline assessment of the ELSA-Brasil study. Exp Gerontol92, 82–86.
45.
KueiderAM, AnY, TanakaT, Kitner-TrioloMH, StudenskiS, FerrucciL, ThambisettyM (2017) Sex-dependent associations of serum uric acid with brain function during aging. J Alzheimers Dis60, 699–706.
46.
AfsarB, ElsurerR, CovicA, JohnsonRJ, KanbayM (2011) Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease. Am J Nephrol34, 49–54.
47.
VannorsdallTD, KueiderAM, CarlsonMC, SchretlenDJ (2014) Higher baseline serum uric acid is associated with poorer cognition but not rates of cognitive decline in women. Exp Gerontol60, 136–139.
48.
ChenX, GuoX, HuangR, ChenY, ZhengZ, ShangH (2014) Serum uric acid levels in patients with Alzheimer’s disease: A meta-analysis. PLoS One9, e94084.
49.
KhanAA, QuinnTJ, HewittJ, FanY, DawsonJ (2016) Serum uric acid level and association with cognitive impairment and dementia: Systematic review and meta-analysis. Age (Dordr)38, 16.
50.
ChoiHK, AtkinsonK, KarlsonEW, WillettW, CurhanG (2004) Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med350, 1093–1103.
SantosCX, AnjosEI, AugustoO (1999) Uric acid oxidation by peroxynitrite: Multiple reactions, free radical formation, and amplification of lipid oxidation. Arch Biochem Biophys372, 285–294.
53.
CiprianiS, DesjardinsCA, BurdettTC, XuY, XuK, SchwarzschildMA (2012) Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson’s disease. PLoS One7, e37331.
54.
DaviesKJ, SevanianA, Muakkassah-KellySF, HochsteinP (1986) Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J235, 747–754.
55.
MiuraT, MuraokaS, OgisoT (1993) Inhibitory effect of urate on oxidative damage induced by adriamycin-Fe3+ in the presence of H2O2. Res Commun Chem Pathol Pharmacol79, 75–85.
56.
YeBS, LeeWW, HamJH, LeeJJ, LeePH, SohnYH, Alzheimer’s Disease Neuroimaging Initiative (2016) Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer’s disease biomarker related cognitive decline?Eur J Neurol23, 948–957.
57.
ManggeH, ZelzerS, PuerstnerP, SchnedlWJ, ReevesG, PostolacheTT, WeghuberD (2013) Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults. Obesity (Silver Spring)21, E71–77.
58.
ZhuY, HuY, HuangT, ZhangY, LiZ, LuoC, LuoY, YuanH, HisatomeI, YamamotoT, ChengJ (2014) High uric acid directly inhibits insulin signalling and induces insulin resistance. Biochem Biophys Res Commun447, 707–714.
59.
FordES, LiC, CookS, ChoiHK (2007) Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation115, 2526–2532.
SchretlenDJ, InscoreAB, VannorsdallTD, KrautM, PearlsonGD, GordonB, JinnahHA (2007) Serum uric acid and brain ischemia in normal elderly adults. Neurology69, 1418–1423.
62.
TanakaA, KawaguchiA, TomiyamaH, IshizuT, MatsumotoC, HigashiY, TakaseB, SuzukiT, UedaS, YamazakiT, FurumotoT, KarioK, InoueT, KobaS, TakemotoY, HanoT, SataM, IshibashiY, MaemuraK, OhyaY, FurukawaT, ItoH, YamashinaA, NodeK (2018) Cross-sectional and longitudinal associations between serum uric acid and endothelial function in subjects with treated hypertension. Int J Cardiol272, 308–313.
63.
PudduP, PudduGM, CraveroE, VizioliL, MuscariA (2012) Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: Molecular mechanisms and clinical implications. J Cardiol59, 235–242.
64.
ZhuY, PandyaBJ, ChoiHK (2011) Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum63, 3136–3141.
65.
LiuB, WangT, ZhaoHN, YuWW, YuHP, LiuCX, YinJ, JiaRY, NieHW (2011) The prevalence of hyperuricemia in China: A meta-analysis. BMC Public Health11, 832.
66.
KesmodelUS (2018) Cross-sectional studies - what are they good for?Acta Obstet Gynecol Scand97, 388–393.
67.
ChoiHK, SorianoLC, ZhangY, RodriguezLA (2012) Antihypertensive drugs and risk of incident gout among patients with hypertension: Population based case-control study. BMJ344, d8190.
68.
UenoS, HamadaT, TaniguchiS, OhtaniN, MiyazakiS, MizutaE, OhtaharaA, OginoK, YoshidaA, KuwabaraM, YoshidaK, NinomiyaH, KotakeH, TaufiqF, YamamotoK, HisatomeI (2016) Effect of antihypertensive drugs on uric acid metabolism in patients with hypertension: Cross-sectional cohort study. Drug Res (Stuttg)66, 628–632.
69.
JiangY, HeT, DengW, SunP (2017) Association between apolipoprotein E gene polymorphism and mild cognitive impairment: A meta-analysis. Clin Interv Aging12, 1941–1949.
70.
ReinvangI, GrambaiteR, EspesethT (2012) Executive dysfunction in MCI: Subtype or early symptom. Int J Alzheimers Dis2012, 936272.
